ReviewCurrent opinion in nephrology and hypertension2025
Therapies in autosomal dominant polycystic kidney disease: beyond tolvaptan.
Christina Fang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it